Literature DB >> 3900267

Effects of flavonoids on insulin secretion and 45Ca2+ handling in rat islets of Langerhans.

C S Hii, S L Howell.   

Abstract

The effects of some flavonoids, a group of naturally occurring pigments one of which has been claimed to possess antidiabetic activities, on insulin release and 45Ca2+ handling have been studied in isolated rat islets of Langerhans. Insulin release was enhanced by approximately 44-70% when islets were exposed to either (-)epicatechin (0.8 mmol/l) or quercetin (0.01-0.1 mmol/l); others such as naringenin (0.1 mmol/l) and chrysin (0.08 mmol/l) inhibited hormone release by approximately 40-60%. These effects were observed only in the presence of 20 mmol glucose/l. Quercetin (0.01 mmol/l) and (-)epicatechin (0.8 mmol/l) both inhibited 45Ca2+ efflux in the presence and absence of extracellular Ca2+. In the presence of 20 mmol glucose/l both the short-term (5 min) and steady-state (30 min) uptake of 45Ca2+ were significantly increased by either quercetin or (-)epicatechin. These results suggest that the stimulatory compounds such as quercetin and (-)epicatechin may, at least in part, exert their effects on insulin release via changes in Ca2+ metabolism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900267     DOI: 10.1677/joe.0.1070001

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  29 in total

1.  Effects of long-term cranberry supplementation on endocrine pancreas in aging rats.

Authors:  Min Zhu; Jingping Hu; Evelyn Perez; Dawn Phillips; Wook Kim; Reza Ghaedian; Joshua K Napora; Sige Zou
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-18       Impact factor: 6.053

2.  Effect of Rebaudioside A, a diterpenoid on glucose homeostasis in STZ-induced diabetic rats.

Authors:  Ramalingam Saravanan; Kaliyappan Vengatash babu; Vinayagam Ramachandran
Journal:  J Physiol Biochem       Date:  2012-02-29       Impact factor: 4.158

3.  Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model.

Authors:  Deepak Chitkara; Sanjay K Nikalaje; Anupama Mittal; Mahesh Chand; Neeraj Kumar
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

4.  Quercetin potentiates transdifferentiation of bone marrow mesenchymal stem cells into the beta cells in vitro.

Authors:  B Miladpour; M Rasti; A A Owji; Z Mostafavipour; Z Khoshdel; A Noorafshan; F Zal
Journal:  J Endocrinol Invest       Date:  2016-12-20       Impact factor: 4.256

5.  Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway.

Authors:  E Youl; G Bardy; R Magous; G Cros; F Sejalon; A Virsolvy; S Richard; J F Quignard; R Gross; P Petit; D Bataille; C Oiry
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 6.  Mechanism of action of natural products used in the treatment of diabetes mellitus.

Authors:  Pranav Kumar Prabhakar; Mukesh Doble
Journal:  Chin J Integr Med       Date:  2011-08-09       Impact factor: 1.978

Review 7.  Cocoa and chocolate in human health and disease.

Authors:  David L Katz; Kim Doughty; Ather Ali
Journal:  Antioxid Redox Signal       Date:  2011-06-13       Impact factor: 8.401

8.  The aqueous extract of Withania coagulans fruit partially reverses nicotinamide/streptozotocin-induced diabetes mellitus in rats.

Authors:  Kirtikar Shukla; Piyush Dikshit; Rimi Shukla; Jasvinder K Gambhir
Journal:  J Med Food       Date:  2012-06-25       Impact factor: 2.786

Review 9.  Impact of dietary polyphenols on carbohydrate metabolism.

Authors:  Kati Hanhineva; Riitta Törrönen; Isabel Bondia-Pons; Jenna Pekkinen; Marjukka Kolehmainen; Hannu Mykkänen; Kaisa Poutanen
Journal:  Int J Mol Sci       Date:  2010-03-31       Impact factor: 5.923

10.  Investigation of Antidiabetic, Antihyperlipidemic, and In Vivo Antioxidant Properties of Sphaeranthus indicus Linn. in Type 1 Diabetic Rats: An Identification of Possible Biomarkers.

Authors:  S Ramachandran; K Asokkumar; M Uma Maheswari; T K Ravi; A T Sivashanmugam; S Saravanan; A Rajasekaran; J Dharman
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.